Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy
- PMID: 24820177
- PMCID: PMC4018255
- DOI: 10.1371/journal.pone.0097225
Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy
Abstract
Background: This study evaluated patterns of treatment failure (especially locoregional failure; LRF) after radical esophagectomy and proposes a clinical target volume (CTV) for postoperative radiotherapy (PORT) among patients with thoracic esophageal squamous cell carcinoma (SCC).
Methods: All patients who were followed up in our center after radical esophagectomy between 2007 and 2011 were retrospectively enrolled. The patterns of first discovered failure were assessed, and LRFs (including anastomotic and regional lymph node recurrences) were evaluated to determine whether our proposed PORT CTV encompassed these areas. The clinicopathologic factors predictive of lymphatic recurrence type were analyzed.
Results: Of the 414 patients who underwent surgery and were followed up over the study, 207 experienced recurrent or metastatic diseases. The median time to progression was 11.0 months. Of the 173 patients with locoregional recurrence, nodal failure recurred in 160; supraclavicular and superior mediastinal lymph nodes had the highest metastasis rates. All 233 recurrent sites across the 160 patients were located in a standard CTV area, including the bilateral supraclavicular areas, the entire mediastinum, and the left gastric lymphatic drainage region. A total of 203 sites (87.2%) were located in either the bilateral supraclavicular areas or the entire mediastinum, and 185 sites (79.4%) were located in either the bilateral supraclavicular areas or the upper mediastinum. A multivariate analysis revealed the lymph node metastatic ratio (LNMR) and tumor differentiation were risk factors for nodal failure.
Conclusions: Locoregional recurrence (especially lymph node recurrence) was the most common and potentially preventable type of initial treatment failure after curative surgery among patients with thoracic esophageal SCC. The proposed PORT CTV covered most LRF sites. The lymphatic drainage regions for PORT are selective, and the supraclavicular and superior mediastinal areas should be considered. However, the value of PORT and the extent of CTV should be investigated in further prospective studies.
Conflict of interest statement
Figures
Similar articles
-
Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer.Thorac Cancer. 2017 Nov;8(6):630-633. doi: 10.1111/1759-7714.12499. Epub 2017 Sep 23. Thorac Cancer. 2017. PMID: 28941320 Free PMC article.
-
[Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):48-55. doi: 10.3760/cma.j.issn.0253-3766.2017.01.010. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28104034 Chinese.
-
[Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):48-54. doi: 10.3760/cma.j.issn.0253-3766.2016.01.010. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 26796807 Chinese.
-
Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):475-82. doi: 10.1016/j.ijrobp.2010.08.037. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2012. PMID: 20934269
-
Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence.Cancer Radiother. 2023 May;27(3):189-195. doi: 10.1016/j.canrad.2022.09.001. Epub 2023 Feb 6. Cancer Radiother. 2023. PMID: 36754752 Review.
Cited by
-
Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial.BMC Cancer. 2023 Mar 15;23(1):249. doi: 10.1186/s12885-023-10687-8. BMC Cancer. 2023. PMID: 36922805 Free PMC article.
-
Tumor Stage-Based Gross Tumor Volume of Resectable Esophageal Squamous Cell Carcinoma Measured on CT: Association With Early Recurrence After Esophagectomy.Front Oncol. 2021 Oct 22;11:753797. doi: 10.3389/fonc.2021.753797. eCollection 2021. Front Oncol. 2021. PMID: 34745986 Free PMC article.
-
Influential factors on radiotherapy efficacy and prognosis in patients with secondary lymph node metastasis after esophagectomy of thoracic esophageal squamous cell carcinoma.Cancer Manag Res. 2018 Feb 2;10:217-225. doi: 10.2147/CMAR.S147324. eCollection 2018. Cancer Manag Res. 2018. PMID: 29440931 Free PMC article.
-
Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study.Thorac Cancer. 2021 Apr;12(8):1180-1186. doi: 10.1111/1759-7714.13891. Epub 2021 Feb 19. Thorac Cancer. 2021. PMID: 33605068 Free PMC article. Clinical Trial.
-
Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma.Radiat Oncol. 2018 Dec 27;13(1):255. doi: 10.1186/s13014-018-1199-3. Radiat Oncol. 2018. PMID: 30587211 Free PMC article.
References
-
- Mirinezhad SK, Somi MH, Seyednezhad F, Jangjoo AG, Ghojazadeh M, et al. (2013) Survival in patients treated with definitive chemo-radiotherapy for non-metastatic esophageal cancer in north- west iran. Asian Pac J Cancer Prev 14: 1677–1680. - PubMed
-
- Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, et al. (2004) Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 198: 205–211. - PubMed
-
- Chen G, Wang Z, Liu XY, Liu FY (2007) Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg 31: 1107–1114. - PubMed
-
- van Hagen P, Wijnhoven BP, Nafteux P, Moons J, Haustermans K, et al. (2013) Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer. Br J Surg 100: 267–273. - PubMed
-
- van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge HM, et al. (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366: 2074–2084. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials